Skip to Content




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent

Chemical Names


4'-deoxy-20',20'-difluoro-8'-norvincaleukoblastine (WHO)

Foreign Names

  • Vinfluninum (Latin)
  • Vinflunin (German)
  • Vinflunine (French)
  • Vinflunina (Spanish)

Generic Names

  • Vinflunine (OS: DCF, BAN)
  • L-0070 (IS)
  • UNII-5BF646324K (IS)
  • Vinflunine Ditartrate (OS: USAN, BANM)
  • BMS-710485 (IS)
  • F-12158 (IS)
  • UNII-33MG53C7XW (IS)

Brand Names

  • Javlor
    Pierre Fabre, Poland; Pierre Farbe Medikament, Greece; Rovafarm, Argentina; Pierre Fabre, Australia; Pierre Fabre, Czech Republic; Pierre Fabre, Denmark; Pierre Fabre, Estonia; Pierre Fabre, Finland; Pierre Fabre, United Kingdom; Pierre Fabre, Ireland; Pierre Fabre, Israel; Pierre Fabre, Lithuania; Pierre Fabre, Netherlands; Pierre Fabre, Norway; Pierre Fabre, Sweden; Pierre Fabre Iberica, Spain; Pierre Fabre Medicament, Singapore; Pierre Fabre Medicament, Slovakia; Pierre Fabre Médicament, France; Pierre Fabre Médicament, Iceland; Pierre Fabre Pharma, Germany
  • Javlor 25 mg/ml
    Pierre Fabre, Austria


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.